Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.
(20AJH130)
The Corporate Presence can provide a range of commemorative designs, including those for FDA approvals, treatment studies, licensing, development, and commercialization agreements, and drug launches. We have unmatched expertise and experience in embedding drug vials.
Crystal tombstone commemorating an exclusive licensing agreement between Ovid Therapuetics and Angelini Pharma. The agreement centers on the development, manufacturing, and commercialization of a potential treatment for Angelman syndrome.
(20AJH130)Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.
(20AMF085)Lucite tombstone commemorating a joint venture between pharmaceutical firms Pfizer and GlaxoSmithKline. The joint venture centers on the over-the-counter consumer healthcare business.
(9AKL489)Pill-themed crystal deal toy commemorating a license agreement between Asahi Kasei Pharma Corporation, headquartered in Tokyo, and New York-based Woolsey Pharmaceuticals.
(9AMF325)Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)Custom crystal commemorating an exclusive distribution agreement between California-based pharmaceutical firm Zogenix and Japanese pharma company Nippon Shinyaku.
(9ALJ481)Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology. The clinical trial sponsored by Clovis involves an ovarian cancer study.
(9ALJ233)
